All News

Survey respondents contradicted prior research that has suggested that manufacturer changes in medication appearance affect perceptions of safety and effectiveness.

This small, 1200-square-foot drugstore will take care of the patients and their problems that the big-box guys could care less about.

The National Association of Boards of Pharmacy (NABP) has issued nearly 50,000 “passports,” or temporary licenses, for pharmacists and pharmacy technicians.

In evaluating data according to the chronic conditions present in the study, those with COPD or depression demonstrated higher reports of social determinants of health than other demographics did.

An exploratory analysis of 2 phase 3 trials evaluating ribociclib (Kisqali, Novartis) plus endocrine therapy in advanced breast cancer showed positive results.

Syndromic surveillance apps may be key in providing solutions to limitations on current COVID-19 case projection data collection efforts.

Oncology pharmacy practitioners highlight challenges amid the pandemic, such as limited access to personal protective equipment and essential medications.

Though antibiotics are crucial, concern about overuse in hospitals and inappropriate prescribing practices fuels debate about the complex relationship between antibiotic use and antimicrobial resistance.

“Err on the side of caution. One large data breach could [affect all] your patients, your employees, and yourself.”

The right products can help manage symptoms of autoimmune diseases.

“As pharmacists, we must continue to recommend vaccinations to all our patients.”

Pharmacists must be tuned in to the latest technology for patients who monitor blood glucose.

Virtual care takes center stage amid the pandemic.

Officials with the FDA have approved imipenem, cilastatin, and relebactam (Recarbrio, Merck) for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia. 

Patients seeking vitamin or herbal supplements for health and wellness often believe that these are safer than conventional OTC and prescription pharmaceutical products; however, so-called natural remedies come with their own set of health risks.

“Are employers really stepping up to take care of their health providers? I think [that] is something that also probably needs to change.”

Here's a roundup of the latest coronavirus-related news.

Julie Ann Justo, PharmD, infectious diseases clinical pharmacist and assistant professor at the University of South Carolina College of Pharmacy, discusses the treatment potential for remdesivir for SARS-CoV-2, as well as distribution strategies for the drug.

Recombinant herpes zoster (HZ) vaccine (Shingrix) induced a strong and persistent immune response in older adults, regardless of previous receipt of live-attenuated HZ vaccine.

A recent analysis showed a surge in prescription fills for hydroxychloroquine/chloroquine, likely due to off-label prescribing for coronavirus disease 2019. 

Survey results reveal improvements and challenges in the workplace.

“Testing is coming, but getting there is a step-by-step process, and you need to work out the logistics.”

Ixekizumab (Taltz, Eli Lilly) is the first interleukin-17A antagonist to be approved for non-radiographic axial spondyloarthritis.

Bristol Myers Squibb announced the commercial US launch of ozanimod (Zeposia) for the treatment of relapsing forms of multiple sclerosis.

Impax requested that pharmacists who have dispensed Impax’s epinephrine injection, USP auto-injector 0.3 mg since December 20, 2018 contact all patients who received the device and provide instructions for inspection.

The study’s authors examined the opportunity to decrease the overall cost of bortezomib by $300-400 million by switching patients to the generic version.

Pharmacies and pharmacists can help the rapid deployment of COVID-19 vaccines when available, NACDS said. 

IW-3718, an investigational adjunct therapy to proton pump inhibitors for refractory GERD, showed favorable results in reducing heartburn severity and other symptoms.